Cyllene, formerly EG 427, has raised €33m in a Series C funding round co-led by GordonMD Global Investments and M Ventures to advance its genetic medicine platform.
Amount Raised
€33 Million
Round Type
Series C
ParisBiotechnologyHealth CareTherapeuticsInvestors
Description
Cyllene has secured €33m in a Series C funding round to support the clinical development of its lead candidate, EG110A. The round was co-led by GordonMD Global Investments and M Ventures, with participation from existing investors. The proceeds will focus on developing therapies for neurogenic bladder conditions following spinal cord injuries. The company aims to initiate a Phase 2b/3 study by 2027.
Quick answer
Cyllene raised €33 Million in a Series C round, dated July 7, 2026. Investors: GordonMD Global Investments, Andera Partners, Bpifrance Investissement, Lamond Ventures and M Ventures. Cyllene is based in Paris, Ile-de-France, France.
- How much did Cyllene raise?
- Cyllene raised €33 Million in a Series C round on July 7, 2026.
- Who invested in Cyllene?
- GordonMD Global Investments, Andera Partners, Bpifrance Investissement, Lamond Ventures and M Ventures are named as investors in this round.
- What does Cyllene do?
- Cyllene, previously known as EG 427, is a Paris-based biotechnology company focused on developing a genetic medicine platform for neurological diseases using non-replicating HSV-1 vectors.
- Where is Cyllene based and how big is it?
- Cyllene is based in Paris, Ile-de-France, France. Fundz records about 400 employees.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as Cyllene that raised within 45 days of this round, from Fundz verified event records.
- Amylyx Pharmaceuticals raised $500M (Post-IPO Equity) on August 20, 2026.
- Kynexis raised $46M (Series A) on August 19, 2026.
- Abcuro raised $66M (Series D) on August 18, 2026.
- bioAffinity Technologies raised $4M (Post-IPO Equity) on August 14, 2026.
- Apollomics raised $10M on August 14, 2026.
- Khartis Therapeutics raised $50M (Series B) on August 13, 2026.
Who to call at Cyllene, and when
A new round usually means Cyllene is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Cyllene raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Cyllene, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Cyllene. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Cyllene raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Cyllene raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.